Search results

• 2021

  Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy

  Ioannou, N., Hagner, P. R., Stokes, M., Gandhi, A. K., Apollonio, B., Fanous, M., Papazoglou, D., Sutton, L-A., Rosenquist, R., Amini, R-M., Chiu, H., Lopez-Girona, A., Janardhanan, P., Awan, F. T., Jones, J., Kay, N. E., Shanafelt, T. D., Tallman, M. S., Stamatopoulos, K., Patten, P. E. M., & 2 othersVardi, A. & Ramsay, A. G., 14 Jan 2021, In: Blood. 137, 2, p. 216-231 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Interferon Type I 100%
  • Programmed Death-Ligand 1 100%
  • B Cell 16%
  • Cytotoxic T-Cell 16%
  • T Cell Activation 16%
  39 Citations (Scopus)

  161 Downloads (Pure)